These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8171712)

  • 21. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
    Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
    Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cytokines, growth factors, and adhesion molecules in rejecting human renal allograft.
    Loong CC; Chen A; Lui WY; King KL; Lin CY
    Transplant Proc; 1996 Jun; 28(3):1445-6. PubMed ID: 8658733
    [No Abstract]   [Full Text] [Related]  

  • 24. Spontaneous improvement of renal function following renal allograft rupture associated with acute rejection.
    Chan TM; Kwok TF; Yap FH; Cheng IK
    Clin Transplant; 1995 Apr; 9(2):71-3. PubMed ID: 7599404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of early biopsy in pediatric kidney transplantation.
    Ishimura T; Ishida T; Fujisawa M
    Aktuelle Urol; 2003 Jul; 34(4):234-8. PubMed ID: 14566671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate is effective in preventing acute and potentially chronic renal allograft rejection.
    Michael B; Francos GC; Burke JF; Gaughan WI
    Transplant Proc; 1994 Oct; 26(5):3046-7. PubMed ID: 7940956
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for chronic rejection in renal allograft recipients.
    Kim HC; Suk J; Joo I; Park SB; Park KK; Cho WH; Park CH
    Transplant Proc; 1996 Jun; 28(3):1456-7. PubMed ID: 8658739
    [No Abstract]   [Full Text] [Related]  

  • 28. SDF-1 expression is elevated in chronic human renal allograft rejection.
    Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK
    Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
    Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
    Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of acute rejection to renal allograft loss from chronic rejection.
    Sumrani N; Cacciarelli TV; Georgi B; Daskalakis P; Miles AM; Goldberg K; Hong JH; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2259-60. PubMed ID: 8516892
    [No Abstract]   [Full Text] [Related]  

  • 31. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 34. Accuracy of resistive and pulsatile indices in the diagnosis of graft rejection in renal allografts.
    Taguchi Y; Koyama I; Shibata T; Sukigara M; Omoto R
    Transplant Proc; 1994 Aug; 26(4):1991-2. PubMed ID: 8066645
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes of chronic kidney allograft rejection are reversible after retransplantation.
    Tullius SG; Heemann UW; Wagner K; Tilney NL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):906-7. PubMed ID: 8442264
    [No Abstract]   [Full Text] [Related]  

  • 37. Utility of biopsy in kidney transplants with delayed graft function and acute dysfunction.
    Silva DM; Garcia JP; Ribeiro AR; Veronese FJ; Edelweiss MI; Gonçalves LF; Manfro RC
    Transplant Proc; 2007 Mar; 39(2):376-7. PubMed ID: 17362734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.
    Piatosa B; Grenda R; Prokurat S
    Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of acute humoral kidney allograft rejection.
    Gomes AM; Pedroso S; Martins LS; Malheiro J; Viscayno JR; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2009 Apr; 41(3):855-8. PubMed ID: 19376371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy.
    Biselli PM; Abbud-Filho M; Ferreira-Baptista MA; de Alvarenga MP; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2006 Jun; 38(5):1327-8. PubMed ID: 16797293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.